Back to results
US 2023/0056721 A1Published application
Inhalable imatinib formulations, manufacture, and uses thereof
AssigneeAerovate Therapeutics, Inc.
InventorsBen Dake, Ralph Niven
Life of this patent
Estimating the term…
Abstract
The invention relates to inhalable imatinib formulations, manufacture, and uses thereof.
Claims20
An inhalable formulation consisting of at least about 50% imatinib or a salt thereof.
A method of treating a condition of the pulmonary cardiovascular system, the method comprising providing to a subject an inhalable formulation consisting of at least about 50% imatinib or a salt thereof.
Dependencies are inferred from the claim text.